Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Cepheid Elects Bishop, Kepner to Board; Evogen Names New Execs

Premium

Cepheid said this week that its board of directors has elected John Bishop as chairman and Cristina Kepner as lead independent director.

Bishop is currently CEO of Cepheid, a position he has held since 2002. He succeeds Thomas Gutshall as chairman. Gutshall will continue to serve on Cepheid's board as a director.

Kepner has been a Cepheid director since 1998. She was formerly executive vice president and corporate finance director of Invemed Associates. She has also served as a director of Monogram Biosciences, and director and chairman of Quipp.


Evogen this week appointed Hans Kastensmith as president and CEO and Robert Dondes as COO.

Kastensmith was founder and president of I-Trax Medical Solutions, and has also served as a partner with Capitol Health Associates and operating partner with Matchpoint Partners.

Dondes has previously served as CEO of Gettysburg Health Administrators and Mid-Atlantic Managed Care Organization; president and CEO of HealthCentral; and Senior Consultant of managed care for The Tompkins Group, among other executive positions with private and publicly traded heathcare companies.

Evogen, based in Lenexa, Kan., provides DNA extraction methodologies, air collection and monitoring products, and proprietary PCR probe technology, among other products.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.